Top Authors

• Most frequent coverage on CGRB

• 
  Mike Huckman (225 followers)

  • Big Pharma's Pheeding Phrenzy (Thu, May 28)
  • J&J Goes to Cougar Town (Fri, May 22)
  • Biopharma: Instead of M&A, Think P&A (Wed, Mar 4)

  More by Mike Huckman on CGRB »
• 
  Zacks.com (1056 followers)

  • J&J Acquiring Cougar, Beefing Up Oncology Portfolio (Fri, May 22)
  • Cougar Bio: Hunting for a Partner? (Thu, May 14)

  More by Zacks.com on CGRB »
• 
  Michael Becker (164 followers)

  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer (Fri, Jun 19)
  • Biotech Stocks and the ASCO-Effect (Mon, Jun 1)

  More by Michael Becker on CGRB »

• Most followed authors on CGRB

• 
  Market Folly (1996 followers)

  • SAC Capital Portfolio Update: 37 13G Filings (Thu, Jan 15)

  More by Market Folly on CGRB »
• 
  Mike Havrilla (1925 followers)

  • Access Pharma: A Smallcap Cancer Biotech Call Option Trade (Thu, May 28)

  More by Mike Havrilla on CGRB »
• 
  Zacks.com (1056 followers)

  • J&J Acquiring Cougar, Beefing Up Oncology Portfolio (Fri, May 22)
  • Cougar Bio: Hunting for a Partner? (Thu, May 14)

  More by Zacks.com on CGRB »

• Newest authors on CGRB

• 
  The Burrill Report (196 followers)

  • Financing Activity May Lift Cloud Hanging over Biotech Industry (Tue, May 26)

  More by The Burrill Report on CGRB »
• 
  Mark Cifra (30 followers)

  • Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly (Wed, May 27)

  More by Mark Cifra on CGRB »
• 
  Michael Becker (164 followers)

  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer (Fri, Jun 19)
  • Biotech Stocks and the ASCO-Effect (Mon, Jun 1)

  More by Michael Becker on CGRB »

• Most commented on CGRB

• 
  Bryan Czyzewski (2 followers)

  • Cougar Biotechnology: Stalking Prostate Cancer (Wed, Jul 2)

  More by Bryan Czyzewski on CGRB »
• 
  Mike Havrilla (1925 followers)

  • Access Pharma: A Smallcap Cancer Biotech Call Option Trade (Thu, May 28)

  More by Mike Havrilla on CGRB »
• 
  Michael Becker (164 followers)

  • Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer (Fri, Jun 19)
  • Biotech Stocks and the ASCO-Effect (Mon, Jun 1)

  More by Michael Becker on CGRB »